These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25769449)

  • 1. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes.
    Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S
    Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
    Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
    Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
    Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
    Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.
    Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M
    Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk.
    Ho V; Ashbury JE; Taylor S; Vanner S; King WD
    Environ Mol Mutagen; 2016 May; 57(4):261-8. PubMed ID: 27062459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study.
    Chang KP; Hao SP; Tsang NM; Chang YL; Cheng MH; Liu CT; Lee YS; Tsai CL; Lee TJ; Wang TH; Tsai CN
    Oncol Rep; 2008 Jan; 19(1):217-22. PubMed ID: 18097598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
    Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
    Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population.
    Aung PP; Matsumura S; Kuraoka K; Kunimitsu K; Yoshida K; Matsusaki K; Nakayama H; Yasui W
    Oncol Rep; 2005 Nov; 14(5):1151-4. PubMed ID: 16211278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
    Huidobro C; Urdinguio RG; Rodríguez RM; Mangas C; Calvanese V; Martínez-Camblor P; Ferrero C; Parra-Blanco A; Rodrigo L; Obaya AJ; Suárez-Fernández L; Astudillo A; Hernando H; Ballestar E; Fernández AF; Fraga MF
    Eur J Cancer; 2012 Sep; 48(14):2270-81. PubMed ID: 22244828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study.
    Fan H; Zhang F; Hu J; Liu D; Zhao Z
    J Exp Clin Cancer Res; 2008 Jul; 27(1):24. PubMed ID: 18662374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer.
    Iacopetta B; Heyworth J; Girschik J; Grieu F; Clayforth C; Fritschi L
    Int J Cancer; 2009 Jul; 125(1):84-90. PubMed ID: 19326430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
    Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
    Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study.
    Jaiswal SK; Sukla KK; Kumari N; Lakhotia AR; Kumar A; Rai AK
    Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):299-305. PubMed ID: 25656965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.
    Bao Q; He B; Pan Y; Tang Z; Zhang Y; Qu L; Xu Y; Zhu C; Tian F; Wang S
    Int J Colorectal Dis; 2011 Sep; 26(9):1107-12. PubMed ID: 21519807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome.
    Coppedè F; Bosco P; Tannorella P; Romano C; Antonucci I; Stuppia L; Romano C; Migliore L
    Hum Reprod; 2013 Feb; 28(2):545-50. PubMed ID: 23081874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT3B polymorphisms and risk of primary lung cancer.
    Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
    Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
    Shen H; Wang L; Spitz MR; Hong WK; Mao L; Wei Q
    Cancer Res; 2002 Sep; 62(17):4992-5. PubMed ID: 12208751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.